Results from the PROfound phase III study, funded by AstraZeneca and Merck Sharp & Dohme, open up a much-needed new treatment avenue for the more precise and effective treatment of patients with ...
STONY BROOK, N.Y., July 10, 2019 /PRNewswire/ -- Schweiger Dermatology Group is excited to announce that it has added the Profound system to their Stony Brook location on Long Island. Profound from ...
LAS VEGAS, Aug. 15, 2018 /PRNewswire-PRWeb/ -- Dr. F. Victor Rueckl is proud to announce the introduction of the revolutionary Profound treatment system to Lakes Dermatology of Las Vegas. Created by ...
TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...
ORLANDO, Fla. — Up to half of all people with severe chronic hand eczema (CHE) who apply delgocitinib cream (Anzupgo) to their hands twice a day have had a profound response to treatment, and about a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback